MEMBER OF CONGRESS

Brett Guthrie

Follow by RSS

Guthrie, a Republican on the Energy and Commerce Committee, spends most of his floor time managing consideration of largely bipartisan bills on health (ALS, breast cancer screening, traumatic brain injury, fentanyl and xylazine) and energy (grid capacity, battery recycling, critical minerals), typically urging a yes vote. His speech is heavily procedural—the signature phrase ‘I yield myself such time as I may consume’ opens nearly every statement, and closing remarks often consist mainly of thanking bill sponsors and yielding time, so much of his airtime goes to floor mechanics rather than argument, far more than most members. When he does argue, he is concrete and mostly free of invective: he cites figures (DERA’s $2.30 in outside funding per federal dollar, 47 million seized fentanyl pills), names bill sponsors across both parties, stresses competition with China on technology and minerals, and frequently ties bills back to Kentucky, as with bluegrass music’s origins in ‘my district.’ His main recurring weak spot is staying on the question: much of his speaking time answers something other than the issue under discussion, usually procedure or thanks, and he occasionally asserts conclusions like California’s emission waiver lacking ‘meaningful, measurable decrease in emissions’ with little supporting detail.Written by AI from their statements. Updated .

Average grade
B+
81 / 100 over 41 statements
Signal 63 / 100
Relevance 97 / 100
Respect Not scored yet
Clarity 95 / 100
Loses points more than most for Throat-clearing: announcing what you are about to say, or the House’s routine business.1.8 times as often as most members.What the tags mean ×1.8 Loses points less than most for Praise, blame or attack with no claim, reason or ask in it.Less often than most members.What the tags mean Averaged over the 41 of 81 statements graded so far.

Statements 81

House of Representatives ·

Action for Dental Health Act

“Dental care is important. I want everyone to vote for this bill.”
Official Congressional Record

Mr. Speaker, I yield myself the balance of my time. Mr. Speaker, I agree with my friend from New Jersey. Dental care is important. I encourage a ``yes’’ vote on the bill, and I yield back the balance of my time.

“I want the House to pass this bill. It gives grants to states to bring more dental workers to areas that do not have enough of them. Good dental care is important for overall health.”
Official Congressional Record

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in strong support of H.R. 2001 led by my colleagues Representative Kelly and Representative Simpson, which reauthorizes a grant program that helps States develop and implement programs to address the need for dental professionals in areas facing a workforce shortage. Oral health is foundational to a person’s overall health, as poor oral health may cause issues with daily tasks, like eating, and negatively impacts a person’s ability to take part in school or work. This legislation is a bipartisan effort to help improve the oral health of all Americans by ensuring that communities across the Nation have access to strong oral health programs despite dental workforce shortages. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

“I want the House to pass this bill. It keeps funding programs that train dentists and help bring dental care to places that need it.”
Official Congressional Record

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 2001) to amend the Public Health Service Act to reauthorize a grant program for addressing dental workforce needs, as amended. The Clerk read the title of the bill. The text of the bill is as follows:

House of Representatives ·

Accelerating Access to Dementia and Alzheimer's Provider Training Act

“I want the House to pass this bill. It keeps funding a program that uses video calls to connect doctors and train them in specialty care. This helps patients in rural areas get better care where they live.”
Official Congressional Record

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 3747, led by my colleagues Representatives Balderson and Barragan, which would reauthorize the technology-enabled collaborative learning program. The technology-enabled collaborative learning program health education model connects healthcare professionals through interactive videoconferencing, which helps meet people where they are by promoting access to specialty care for people who otherwise may not be able to access it because of where they live. This is a valuable tool for clinicians to both continue learning and improve existing knowledge of best practices to support and care for patients in their communities. This is particularly effective for patients in rural communities, and I represent many. Mr. Speaker, I am proud to support this legislation. I encourage my colleagues to support this bill, and I reserve the balance of my time.

“I want the House to pass this bill. It funds training programs to help doctors and health workers care for people with Alzheimer's and dementia.”
Official Congressional Record

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3747) to amend the Public Health Service Act to reauthorize the Project ECHO Grant Program, to establish grants under such program to disseminate knowledge and build capacity to address Alzheimer’s disease and other dementias, and for other purposes, as amended. The Clerk read the title of the bill. The text of the bill is as follows:

House of Representatives ·

Stem Cell Therapeutic and Research Reauthorization Act of 2025

“I am letting the representative from Florida speak.”
Official Congressional Record

Mr. Speaker, I yield such much time as he may consume to the gentleman from Florida (Mr. Bilirakis), a very important member of our committee and chairman of the Commerce, Manufacturing, and Trade Subcommittee.

“I support this bill. It keeps programs going that help patients find bone marrow and cord blood donors when their own families cannot donate. These transplants can save lives when other treatments fail.”
Official Congressional Record

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 5160, led by my colleagues Representatives Smith and Matsui to reauthorize the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. The C.W. Bill Young Cell Transplantation Program supports patients across the country with identifying matching and facilitating the distribution of bone marrow peripheral blood stem cells and cord blood donors for those who need blood stem cell transplants. This is critically important for those patients without a related family member who is unable to donate. For some patients, blood stem cell transplants are an opportunity for remission or even a cure when other treatments have failed. This bill ensures patients have access to these lifesaving opportunities. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

“I am asking the House to pass this bill to keep funding stem cell and bone marrow transplant programs.”
Official Congressional Record

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5160) to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes, as amended. The Clerk read the title of the bill. The text of the bill is as follows:

House of Representatives ·

Reauthorizing the Kay Hagan Tick Act

“I want everyone to vote for this bill.”
  • Speech on a bill

    Signal 10 of 100

    Much of this statement went to praise, blame, greetings, routine procedure or general stories rather than reasons, requests or specific points.

    See full analysis
Official Congressional Record

Mr. Speaker, I encourage a ``yes’’ vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore (Mr. Newhouse). The question is on the motion offered by the gentleman from Kentucky (Mr. Guthrie) that the House suspend the rules and pass the bill, H.R. 4348. The question was taken; and (two-thirds being in the affirmative) the rules were suspended and the bill was passed. A motion to reconsider was laid on the table.

“I want the House to pass this bill. It funds programs to stop dangerous diseases spread by ticks, mosquitoes, and fleas.”
Official Congressional Record

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in strong support of H.R. 4348, led by my colleagues, the gentleman from New Jersey (Mr. Smith) and the gentleman from Texas (Mr. Doggett), which authorizes the national and regional centers for excellence in vector-borne disease in the CDC’s cooperative agreements with health departments in high-risk areas for vector-borne diseases. Vectors like mosquitoes, ticks, and fleas carry dangerous diseases, and vector-borne diseases can happen to anyone. They can have debilitating effects. Preventing these diseases is a bipartisan issue that I hope we all can support. In addition to thanking the bill’s sponsors for their leadership in advancing the efforts to reduce the alarming threat of vector-borne disease, I also thank the administration for their support of this bill and for their commitment to the American people by combating Lyme disease, which affects almost half a million Americans annually. I encourage my colleagues to support this bill, and I reserve the balance of my time.

“I am asking the House to pass this bill to keep funding programs that fight diseases spread by ticks and mosquitoes.”
Official Congressional Record

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 4348) to reauthorize the Kay Hagan Tick Act, and for other purposes. The Clerk read the title of the bill. The text of the bill is as follows:

House of Representatives ·

FDA Modernization Act 3.0

“I am giving my speaking time to Representative Carter, who is a leader on this issue.”
Official Congressional Record

Mr. Speaker, I yield such time as he may consume to the gentleman from Georgia (Mr. Carter), a dear friend, a great member of the Energy and Commerce Committee, and a leader in this effort with the FDA. With pharmaceuticals, just about anything that is very important to the American people, he is an absolute leader in that.

“I support this bill. It updates drug testing rules so scientists can use modern testing methods instead of animals whenever possible.”
Official Congressional Record

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 2821, led by my colleagues Representative Carter of Georgia and Representative Barragan, which requires the Secretary of HHS to publish rules amending certain regulations by replacing references to ``animal’’ tests, data, studies, models, and research with the broader term ``nonclinical’’ tests, data, studies, models, and research. Biomedical research typically utilizes animal models to explore biological processes, analyze diseases, and explore potential therapies. However, given the concerns and scientific limitations of animal testing, researchers have increasingly turned to new approach methodologies to evaluate drugs when scientifically justified. The scientific community has worked diligently to balance animal welfare concerns and the value of animal tests and research. I am pleased with the progress to date and look forward to seeing continued evidence-driven advancements in this space. I commend the administration for their work to phase out animal testing where it is scientifically appropriate and for achieving the key goals in the first year of implementing the roadmap to reducing animal testing in preclinical safety studies. Mr. Speaker, I appreciate my colleague from Georgia for putting this bill forward, and I reserve the balance of my time.

“I want the House to pass this bill. It tells the FDA to make final rules on testing methods that do not use animals.”
Official Congressional Record

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 2821) to require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods. The Clerk read the title of the bill. The text of the bill is as follows:

House of Representatives ·

Destruction of Hazardous Imports Act

“I support this bill. When dangerous food or illegal drugs are stopped at our borders, officials cannot destroy them. Shippers just try to bring them in through another port until they get through. The FDA needs the power to destroy these products.”
Official Congressional Record

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I really appreciate my friends from Louisiana, both of them, for bringing this forward. This is important. Think about what we are talking about here. Contaminated seafood, illicit drugs, and all of these other things are getting stopped at a port of entry, but FDA has no authority to destroy them. As my friend from New Jersey said, they get returned and come in through another port. As good as our people are at our ports of entry, if you keep sending the same thing through over and over, eventually it is going to get through. It makes no sense not to allow the FDA to destroy these products. Mr. Speaker, I support this bill, and I reserve the balance of my time.

“Representative Higgins and Representative Carter sponsored this bill. I am giving Representative Higgins time to speak.”
Official Congressional Record

Mr. Speaker, it looks like we have two friends from Louisiana supporting this and who sponsored this bill today, Mr. Higgins and Mr. Carter. Mr. Speaker, I yield 5 minutes to the gentleman from Louisiana (Mr. Higgins).

“I am asking the House to pass this bill. It lets the government destroy unsafe imported goods instead of sending them back.”
Official Congressional Record

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 2715) to amend the Federal Food, Drug, and Cosmetic Act to extend the destruction authority of the Secretary of Health and Human Services to articles that present a significant public health concern, and for other purposes, as amended. The Clerk read the title of the bill. The text of the bill is as follows:

House of Representatives ·

Choices for Increased Mobility Act of 2026

“I want the House to pass this bill. It helps people on Medicare get better wheelchairs to move around more easily.”
Official Congressional Record

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 1703, led by my good friend who previously spoke, the gentleman from Pennsylvania (Mr. Joyce). Medicare beneficiaries should not be limited in their ability to access the right wheelchair to help them move freely in their daily lives. Ultimately, the payment clarifications in this legislation are intended to improve access to wheelchair upgrades among Medicare beneficiaries who choose to do so. I encourage my colleagues to support this bill. Mr. Speaker, I have no further speakers on this bill, and I reserve the balance of my time.

“I am giving my time to Representative Joyce to speak.”
Official Congressional Record

Mr. Speaker, I yield such time as he may consume to the gentleman from Pennsylvania (Mr. Joyce), my good friend, the sponsor of this legislation, a valuable member of the Energy and Commerce Committee, and head of the Subcommittee on Oversight and Investigations.

“I want the House to pass this bill. It clarifies Medicare payment rules for manual wheelchairs.”
Official Congressional Record

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 1703) to amend title XVIII of the Social Security Act to clarify payment rules for manual wheelchairs under part B of the Medicare program, as amended. The Clerk read the title of the bill. The text of the bill is as follows: